Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility
- PMID: 26756097
- DOI: 10.1021/acs.jmedchem.5b01559
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility
Abstract
4-Quinolone-3-carboxamide derivatives have long been recognized as potent and selective cannabinoid type-2 receptor (CB2R) ligands. With the aim to improve their physicochemical properties, basically aqueous solubility, two different approaches were followed, entailing the substitution of the alkyl chain with a basic replacement or scaffold modification to 4-hydroxy-2-quinolone structure. According to the first approach, compound 6d was obtained, showing slightly reduced receptor affinity (K(i) = 60 nM) compared to the lead compound 4 (0.8 nM) but greatly enhanced solubility (400-3400 times depending on the pH of the medium). On the other hand, shifting from 4-quinolone to 4-hydroxy-2-quinolone structure enabled the discovery of a novel class of CB2R ligands, such as 7b and 7c, characterized by K(i) < 1 nM and selectivity index [SI = K(i)(CB1R)/K(i)(CB2R)] > 1300. At pH 7.4, compound 7c resulted by 100-fold more soluble than 4.
Similar articles
-
Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors.Eur J Med Chem. 2012 Dec;58:30-43. doi: 10.1016/j.ejmech.2012.09.035. Epub 2012 Oct 3. Eur J Med Chem. 2012. PMID: 23085772
-
Investigations on the 4-quinolone-3-carboxylic acid motif. 4. Identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and antihyperalgesic effects in mice.J Med Chem. 2011 Aug 11;54(15):5444-53. doi: 10.1021/jm200476p. Epub 2011 Jul 6. J Med Chem. 2011. PMID: 21702498
-
Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands.J Med Chem. 2010 Aug 26;53(16):5915-28. doi: 10.1021/jm100123x. J Med Chem. 2010. PMID: 20718492
-
Perspectives of Cannabinoid Type 2 Receptor (CB2R) Ligands in Neurodegenerative Disorders: Structure-Affinity Relationship (SAfiR) and Structure-Activity Relationship (SAR) Studies.J Med Chem. 2017 Dec 28;60(24):9913-9931. doi: 10.1021/acs.jmedchem.7b00155. Epub 2017 Jun 30. J Med Chem. 2017. PMID: 28608697 Review.
-
The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry.Curr Med Chem. 2009;16(14):1746-67. doi: 10.2174/092986709788186156. Curr Med Chem. 2009. PMID: 19442143 Review.
Cited by
-
Screen of Unfocused Libraries Identified Compounds with Direct or Synergistic Antibacterial Activity.ACS Med Chem Lett. 2020 Mar 6;11(5):899-905. doi: 10.1021/acsmedchemlett.9b00674. eCollection 2020 May 14. ACS Med Chem Lett. 2020. PMID: 32435403 Free PMC article.
-
BiCl3-catalyzed green synthesis of 4-hydroxy-2-quinolone analogues under microwave irradiation.RSC Adv. 2023 Sep 21;13(40):28030-28041. doi: 10.1039/d3ra05289c. eCollection 2023 Sep 18. RSC Adv. 2023. PMID: 37746335 Free PMC article.
-
Study on the regioselectivity of the N-ethylation reaction of N-benzyl-4-oxo-1,4-dihydroquinoline-3-carboxamide.Beilstein J Org Chem. 2019 Feb 12;15:388-400. doi: 10.3762/bjoc.15.35. eCollection 2019. Beilstein J Org Chem. 2019. PMID: 30873225 Free PMC article.
-
Synthesis and Preliminary Biological Evaluation of Indol-3-yl-oxoacetamides as Potent Cannabinoid Receptor Type 2 Ligands.Molecules. 2017 Jan 4;22(1):77. doi: 10.3390/molecules22010077. Molecules. 2017. PMID: 28054997 Free PMC article.
-
Rational drug design of CB2 receptor ligands: from 2012 to 2021.RSC Adv. 2022 Dec 8;12(54):35242-35259. doi: 10.1039/d2ra05661e. eCollection 2022 Dec 6. RSC Adv. 2022. PMID: 36540233 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information